4//SEC Filing
Lacey David L. 4
Accession 0001209191-21-038623
CIK 0001724521other
Filed
Jun 6, 8:00 PM ET
Accepted
Jun 7, 4:38 PM ET
Size
7.3 KB
Accession
0001209191-21-038623
Insider Transaction Report
Form 4
Lacey David L.
Director
Transactions
- Award
Common Stock
2021-06-03+3,000→ 38,352 total - Award
Stock Option (Right to Buy)
2021-06-03+14,100→ 14,100 totalExercise: $24.79Exp: 2031-06-02→ Common Stock (14,100 underlying)
Footnotes (2)
- [F1]Represents the grant of restricted stock units that vest 100% on the earlier of June 3, 2022 or the next annual meeting of the stockholders of the issuer. The RSUs will become fully vested in the event the Company is subject to a change in control.
- [F2]The option will vest in full on the earlier of (i) 12 months following the date of grant or (ii) the date of the next annual stockholder meeting following the grant. The option becomes fully vested and exercisable in the event the Company is subject to a change in control.
Documents
Issuer
Arcus Biosciences, Inc.
CIK 0001724521
Entity typeother
Related Parties
1- filerCIK 0001734422
Filing Metadata
- Form type
- 4
- Filed
- Jun 6, 8:00 PM ET
- Accepted
- Jun 7, 4:38 PM ET
- Size
- 7.3 KB